Pharmala Biotech Holdings Inc. (MDMA.CN)
CAD 0.14
(-3.45%)
CAD 0.14
(-3.45%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 58.49 Thousand CAD | 106.86% |
| 2022 | -852.13 Thousand CAD | 65.53% |
| 2021 | -2.47 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -222.84 Thousand CAD | -480.97% |
| 2024 Q3 | -495.8 Thousand CAD | -1128.86% |
| 2024 Q2 | -40.34 Thousand CAD | 81.89% |
| 2023 Q4 | 58.49 Thousand CAD | 111.79% |
| 2023 FY | 58.49 Thousand CAD | 106.86% |
| 2023 Q2 | -731.72 Thousand CAD | -0.17% |
| 2023 Q3 | -495.99 Thousand CAD | 32.22% |
| 2023 Q1 | -730.46 Thousand CAD | 14.28% |
| 2022 Q4 | -852.13 Thousand CAD | 29.04% |
| 2022 Q3 | -1.2 Million CAD | 35.04% |
| 2022 Q2 | -1.84 Million CAD | 13.9% |
| 2022 Q1 | -2.14 Million CAD | 0.0% |
| 2022 FY | -852.13 Thousand CAD | 65.53% |
| 2021 FY | -2.47 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -125.08 Thousand CAD | 146.764% |
| Asep Medical Holdings Inc | -44.72 Thousand CAD | 230.8% |
| BetterLife Pharma Inc. | 207.85 Thousand CAD | 71.857% |
| BioVaxys Technology Corp. | -977.00 CAD | 6087.206% |
| ChitogenX Inc. | 3.84 Million CAD | 98.477% |
| Rapid Dose Therapeutics Corp. | 2.29 Million CAD | 97.449% |
| Defence Therapeutics Inc. | 1.68 Million CAD | 96.539% |
| Entheon Biomedical Corp. | -344.63 Thousand CAD | 116.973% |
| Gemina Laboratories Ltd. | 284.33 Thousand CAD | 79.428% |
| Glow Lifetech Corp. | 116.15 Thousand CAD | 49.638% |
| Lexston Life Sciences Corp. | -390.4 Thousand CAD | 114.983% |
| Doseology Sciences Inc. | -1.06 Million CAD | 105.517% |
| MYND Life Sciences Inc. | 2.99 Million CAD | 98.05% |
| Nova Mentis Life Science Corp. | -8088.00 CAD | 823.232% |
| PharmaTher Holdings Ltd. | -2.13 Million CAD | 102.742% |
| PreveCeutical Medical Inc. | 3.83 Million CAD | 98.474% |
| Telescope Innovations Corp. | -719.49 Thousand CAD | 108.13% |